COVID-19 updates - Get the latest information about Coronavirus and Iowa Heart Center

Paraglide HF

Purpose of Study

To assess the effect of in-hospital initiation of sacubitril/valsartan in patients with HFpEF who have been stabilized during hospitalization for acute decompensated heart failure, elevated NT-proBNP or BNP during current hospitalization

Trial Status


Eligibility Criteria

40 years of age or older, currently hospitalized with acute decompensated HFpEF

Duration of Participation

Approximately 18 weeks

Contact Name: Megan Murphy, RN

Contact Phone: 515-235-5089

Contact Email: